Label for an inhaler
Latest Celon Pharma S.A. Patents:
- 3-phenyl-4-hexynoic acid derivatives as GPR40 agonists
- Ketamine composition for use in a method of treatment of depression by pulmonary administration
- Pyrazole[1,5-a] pyrimidine derivatives as kinase JAK inhibitors
- 3-PHENYL-4-HEXYNOIC ACID DERIVATIVES AS GPR40 AGONISTS
- DRY POWDER KETAMINE COMPOSITION FOR USE IN THE TREATMENT OF DEPRESSION BY PULMONARY ADMINISTRATION
Description
The FIGURE is a front view of a label for an inhaler.
Claims
The ornamental design for a label for an inhaler, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
Other references
635098 | October 1899 | Henckel |
D241539 | September 1976 | Iverson |
D342994 | January 4, 1994 | Rand et al. |
5937554 | August 17, 1999 | Haugk |
D416050 | November 2, 1999 | Caloia |
D438699 | March 13, 2001 | Campman |
D590495 | April 14, 2009 | Lulla et al. |
D667105 | September 11, 2012 | Zuyderhoudt |
D684254 | June 11, 2013 | Zuyderhoudt |
D692953 | November 5, 2013 | Biesel |
D693458 | November 12, 2013 | Wright et al. |
D737425 | August 25, 2015 | Wieczorek |
20040035420 | February 26, 2004 | Davies et al. |
20050174216 | August 11, 2005 | Lintell |
20050177275 | August 11, 2005 | Harvey et al. |
20070125372 | June 7, 2007 | Chen |
20120260917 | October 18, 2012 | Bilgic |
20140025508 | January 23, 2014 | Bartosch |
001842220-0001 | March 2011 | EM |
001842220-0002 | March 2011 | EM |
001842220-0003 | March 2011 | EM |
002226407-0001 | April 2013 | EM |
002226407-0002 | April 2013 | EM |
002256834-0001 | June 2013 | EM |
002256834-0002 | June 2013 | EM |
2242134 | September 1991 | GB |
- “The GlaxoSmithKline Diskus”, beachpackagingdesign.com/wp/2012/02/technical-packaging-the-diskusaccuhaler.html, Beach packaging Design, Staten Island, NY, Feb. 1, 2012, downloaded from the Internet on Feb. 11, 2014.
- Design U.S. Appl. No. 29/480,609, Co-owned.
- Design U.S. Appl. No. 29/478,329, filed Jan. 3, 2013.
Patent History
Patent number: D759163
Type: Grant
Filed: Jan 28, 2014
Date of Patent: Jun 14, 2016
Assignee: Celon Pharma S.A. (Kielpin)
Inventors: Bogdan Szczepan Manowski (Kielpin), Maciej Wieczorek (Kielpin)
Primary Examiner: Mary Ann Calabrese
Application Number: 29/480,631
Type: Grant
Filed: Jan 28, 2014
Date of Patent: Jun 14, 2016
Assignee: Celon Pharma S.A. (Kielpin)
Inventors: Bogdan Szczepan Manowski (Kielpin), Maciej Wieczorek (Kielpin)
Primary Examiner: Mary Ann Calabrese
Application Number: 29/480,631
Classifications
Current U.S. Class:
Label Or Tag (6) (D20/22)